Abivax (ABVX) Earnings Analysis

Abivax (ABVX) next reports earnings on 2026-09-14, consensus EPS -0.95851 USD. Last quarter (2026-05-22) it beat with EPS -0.70299 USD vs -0.93593 USD est (+24.9%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -23.48.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ABVX next report earnings?

Next earnings date2026-09-14
Consensus EPS estimate-0.95851 USD
Revenue estimate0.00B

ABVX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-22-0.70299 USD-0.93593 USD+24.9%Beat
2026-03-23-1.2043 USD-1.07 USD-12.6%Miss
2025-09-08-0.86 USD-0.9 USD+4.4%Beat
2025-03-24-1.55066 USD-0.68 USD-128%Miss

Beat rate: 2/4 (50%) over reported quarters with consensus data.

ABVX valuation and analyst view

Trailing P/E-23.48
Trailing EPS-4.8341 USD
Price / book17.32
Dividend yield0.00%
Market cap9.58B
Analyst consensusBuy (12 buy / 1 hold / 0 sell)
Avg price target138.44 USD

Related research pages

Frequently asked questions

When is Abivax (ABVX)'s next earnings date?

Abivax is next scheduled to report on 2026-09-14, with a consensus EPS estimate of -0.95851 USD and revenue estimate of 0.00B.

Did ABVX beat earnings last quarter?

In its 2026-05-22 report, ABVX posted EPS of -0.70299 USD versus a -0.93593 USD estimate — a beat of 24.9%.

What is ABVX's earnings track record?

Over the last 4 reported quarters with consensus data, ABVX beat estimates 2 times (50%).

What is ABVX's current P/E ratio and EPS?

ABVX trades at a trailing P/E of -23.48 on trailing EPS of -4.834100094329833 USD.

What do analysts rate ABVX?

Analyst consensus is "Buy" across 13 ratings (0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 138.44 USD.